{"id":98559,"date":"2023-05-09T00:00:00","date_gmt":"2023-05-09T00:00:00","guid":{"rendered":"https:\/\/medgoo.com\/index.php\/2023\/05\/09\/population-genomic-screening-for-three-conditions-likely-cost-effective\/"},"modified":"2023-05-09T00:00:00","modified_gmt":"2023-05-09T00:00:00","slug":"population-genomic-screening-for-three-conditions-likely-cost-effective","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2023\/05\/09\/population-genomic-screening-for-three-conditions-likely-cost-effective\/","title":{"rendered":"Population Genomic Screening for Three Conditions Likely Cost-Effective"},"content":{"rendered":"<h3>\n<p>Genomic screening for Lynch syndrome, hereditary breast and ovarian cancer syndrome, and familial hypercholesterolemia likely cost-effective for adults younger than 40 years<\/p>\n<\/h3>\n<p><b>By Elana Gotkine HealthDay Reporter<\/b><\/p>\n<p><b><\/b><\/p>\n<p>TUESDAY, May 9, 2023 (HealthDay News) &#8212; Conducting screening tests for three common genetic disorders could be cost-effective at a population level for adults younger than 40 years of age, according to a study published online May 9 in the <em>Annals of Internal Medicine<\/em>.<em><\/em><\/p>\n<p>Gregory F. Guzauskas, M.S.P.H., Ph.D., from the University of Washington in Seattle, and colleagues estimated the cost-effectiveness of simultaneous genomic screening for Lynch syndrome, hereditary breast and ovarian cancer syndrome, and familial hypercholesterolemia in separate age-based cohorts of racially and ethnically representative U.S. adults.<\/p>\n<p>The researchers found that screening 100,000 unselected 30-year-olds resulted in 101 and 15 fewer overall cancer cases and cardiovascular events, respectively, and an increase of 495 quality-adjusted life years (QALYs) at an incremental cost of $33.9 million in the base-case analysis. Per QALY gained, the incremental cost-effectiveness ratio was $68,600. In a sensitivity analysis, screening 30-, 40-, and 50-year-old cohorts was cost-effective in 99, 88, and 19 percent of probabilistic simulations, respectively, at the threshold of $100,000 per QALY. Screening 30-, 40-, and 50-year-olds reached this threshold at test costs of $413, $290, and $166, respectively. Highly influential parameters included prevalence of variants and adherence to preventive interventions.<\/p>\n<p>&#8220;Our analysis indicates that screening with a limited panel of high-evidence genes associated with three U.S. Centers for Disease Control and Prevention Tier 1 conditions is likely to be cost-effective with an appropriate test cost for U.S. adults younger than 40 years,&#8221; the authors write.<\/p>\n<p><a href=\"https:\/\/www.acpjournals.org\/doi\/10.7326\/M22-0846\" target=\"_blank\" rel=\"noopener\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2023 <a href=\"http:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Genomic screening for Lynch syndrome, hereditary breast and ovarian cancer syndrome, and familial hypercholesterolemia likely cost-effective for adults younger than 40 years<\/p>\n","protected":false},"author":6,"featured_media":98560,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-98559","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/98559","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=98559"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/98559\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/98560"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=98559"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=98559"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=98559"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}